{"tid":2108888,"cid":5,"subCid":0,"title":"【In US, We trust】Moderna:新冠疫苗初期人體測試效果佳","createTime":"2020-07-15T00:57:37.000Z","updateTime":"2020-07-15T01:13:20.000Z","uid":108201,"like":2,"dislike":1,"uniUserReply":4,"replies":[{"pid":"2e97b18de5c5cd62bb9f5a6d5391d9235f4cc884","tid":2108888,"uid":108201,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-07-15T00:57:37.000Z","msg":"美國生化科技公司莫德納(Moderna)本月底將展開新冠病毒疫苗後期人體測試，集團最新披露，初期人體測試數據顯示，所有獲注射mRNA-1273疫苗的病人都安全，並且都有產生抗體，反映疫苗效果良好。<br />\n<br />\n消息曝光後，Moderna市後時段股價急升16%。<br />\n<br />\nModerna周二較早時公布，將於本月27日展開疫苗後期人體測試，對3萬人展開注射及研究。<br />\n<br />\nModerna其後在《新英格蘭醫學雜誌》(New England Journal of Medicine)發表研究報告，表示初期人體測試時，全部45個病人經過兩輪注射後，均產生免疫抗體，沒有人感到嚴重不適，只有半數人有輕微不適，結果令人鼓舞。<br />\n<br />\nModerna成為首個就疫苗進行人體測試的生化藥廠，5月公布初期人體測試初步結果，當時未有提交數據，資料也未經外間評審。"},{"pid":"de1fbb6b974dcb0ac7d16077364db743df8935d4","tid":2108888,"uid":24160,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-07-15T01:07:50.000Z","msg":"武漢肺炎先啱呀 唔係新冠囉"},{"pid":"4510526cea7dcb3f557ac8497968acf0d577e730","tid":2108888,"uid":40267,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-07-15T01:10:13.000Z","msg":"過到第三期先講啦"},{"pid":"e24e190455b1e63c4a4333d9195a4085b5df2db9","tid":2108888,"uid":54593,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-07-15T01:13:20.000Z","msg":"中國幾時制裁埋Moderna <img src=\"/assets/faces/pig/angry.gif\" class=\"hkgmoji\" />"}]}